Here's the live share price of Parnax Lab along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Parnax Lab has gained 54.73% CAGR. Over the past year, the corresponding return has been 15.24%.
Parnax Lab’s current P/E of 14.36x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Parnax Lab | -0.25 | 9.45 | 31.32 | 60.10 | 15.79 | 18.12 | 54.87 |
Sun Pharmaceutical Industries | 0.99 | -1.32 | -4.43 | -5.58 | -13.53 | 22.86 | 25.44 |
Divi's Laboratories | 1.35 | -1.39 | -9.09 | 7.26 | 10.98 | 19.38 | 13.39 |
Cipla | 0.28 | -0.53 | 1.92 | 4.23 | -6.24 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -2.95 | -3.25 | 7.81 | 15.50 | 2.38 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 1.28 | 3.65 | -2.73 | 13.87 | -1.48 | 17.07 | 7.18 |
Mankind Pharma | -0.83 | 3.97 | 8.45 | 18.23 | 4.55 | 21.72 | 12.52 |
Zydus Lifesciences | -0.29 | 4.77 | 6.12 | 15.71 | -7.35 | 42.05 | 21.62 |
Lupin | 4.71 | 4.15 | 2.02 | 3.02 | -8.93 | 48.04 | 14.81 |
Abbott India | 1.23 | -4.93 | -2.02 | 2.81 | 6.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.35 | 3.02 | 13.21 | 14.40 | -13.33 | 20.01 | 14.29 |
Aurobindo Pharma | 4.59 | 0.18 | -4.54 | -1.88 | -30.10 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -1.88 | 5.17 | 23.41 | 45.12 | 19.22 | 77.31 | 32.95 |
Laurus Labs | -0.75 | 3.48 | 31.71 | 54.01 | 77.48 | 20.12 | 27.15 |
Biocon | -1.28 | -1.15 | 0.76 | 7.82 | -7.87 | 7.34 | -3.86 |
Anthem Biosciences | 2.21 | 4.53 | 14.60 | 14.60 | 14.60 | 4.65 | 2.76 |
GlaxoSmithKline Pharmaceuticals | -2.60 | -1.60 | -18.46 | 1.95 | -3.00 | 24.23 | 9.16 |
Cohance Lifesciences | -2.90 | 10.08 | -0.45 | -12.87 | -15.54 | 28.96 | 21.52 |
Ipca Laboratories | -0.61 | -5.32 | -3.76 | -0.34 | -10.15 | 14.97 | 3.52 |
Gland Pharma | 5.03 | 2.24 | 13.95 | 29.79 | 8.06 | -4.20 | 2.06 |
Over the last one year, Parnax Lab has gained 15.79% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Parnax Lab has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 139.37 | 137.44 |
10 | 134.49 | 135.64 |
20 | 130.93 | 132.16 |
50 | 121.74 | 124.22 |
100 | 110.97 | 118.73 |
200 | 122.13 | 117.6 |
In the latest quarter, Parnax Lab remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 27.70% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 06, 2025, 11:44 PM IST | Parnax Lab L - Reg. 34 (1) Annual Report. |
Sep 06, 2025, 11:21 PM IST | Parnax Lab L - Notice Of 43Rd Annual General Meeting Schedule To Be Held On Monday, 29Th September, 2025. |
Aug 29, 2025, 8:27 PM IST | Parnax Lab L - Corporate Action- Fixes Book Closure For Annual General Meeting. |
Aug 13, 2025, 10:43 PM IST | Parnax Lab L - Intimation Of Appointment Of Secretarial Auditor Under Regulation 24(A) And Regulation 30 Of SEBI (Listing Obl |
Aug 13, 2025, 10:38 PM IST | Parnax Lab L - Financial Results For The Quarter Ended June 30, 2025. |
Parnax Lab Ltd. is a Public Limited Listed company incorporated on 03/08/1982 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L36912MH1982PLC027925 and registration number is 027925. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 7.02 Cr. and Equity Capital is Rs. 11.49 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Parnax Lab is ₹138.35 as on Sep 16, 2025.
The Parnax Lab is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Parnax Lab is ₹155.23 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Parnax Lab are ₹139.25 and ₹135.15.
The 52-week high/low is the highest and lowest price at which Parnax Lab stock has traded in the past 52-week or nearly a year. The 52-week high of Parnax Lab is ₹193.50 and 52-week low of Parnax Lab is ₹81.00 as on Sep 16, 2025.
The Parnax Lab has shown returns of -0.25% over the past day, 8.94% for the past month, 30.7% over 3 months, 15.24% over 1 year, 17.93% across 3 years, and 54.73% over 5 years.
P/E ratio of and PB ratio of Parnax Lab are 14.36 and 1.97 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.